Insider Trends: ResMed Insider Disposition Interrupting 90-Day Buy Trend
01:13 PM EST, 02/05/2021 (MT Newswires) -- David Pendarvis, Chief Administrative Officer, sold 1,487 shares in ResMed (RMD) on Feb 03, 2021, for $303,973. Following the Form 4 filing with the SEC, Pendarvis has 132,268 shares of the company, which have a market value of $27.0 million as of the prior-day closing price.
In the 90 days prior to the date of this filing, there have been 50 insider transactions reported to the SEC for ResMed. These transactions came from the activities of 14 individual insiders that resulted in a net acquisition of 111,128 company shares. In the preceding 90-day window of time, there were 27 transactions from 8 insiders which resulted in the net acquisition of 20,667 shares.
This is lower than the average level of insider transactions in the 100-company Advanced Medical Equipment & Technology peer group over the last 90-day period. Activity in the peer group averaged 103.5 transactions per company, and disposition of 3,470 shares on average.
SEC Story Link http://www.sec.gov/Archives/edgar/data/943819/000112760221004154/xslF345X03/form4.xml
This report does not constitute a recommendation to purchase or sell any security and the analysts are not registered investment advisors. Further analysis is recommended before undertaking any position in any security. Any risks are solely the responsibility of the buyer/seller. The authors, publishers and distributors of the MT Newswires Live Briefs service and any associates thereof accept no liability for the content or actions taken by anyone or institution utilizing this report.